Document Detail


Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study.
MedLine Citation:
PMID:  20937946     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Whether insulin resistance predicts ischemic stroke (IS) is still a matter of debate.
OBJECTIVE: To determine the association between insulin resistance (IR) and risk of first ischemic stroke in a large, multiethnic, stroke-free cohort without diabetes.
DESIGN: Prospective, population-based cohort study.
SETTING: Longitudinal epidemiologic study.
PARTICIPANTS: A cohort of 1509 nondiabetic participants from the Northern Manhattan Study (mean [SD] age, 11 [10] years; 64.2% women; 58.9% Hispanics).
MAIN OUTCOME MEASURES: Insulin sensitivity, expressed by the homeostasis model assessment (HOMA) of insulin sensitivity (HOMA index = [fasting insulin × fasting glucose] / 22.5). Insulin resistance was defined by a HOMA-IR index in the top quartile (Q4). Cox proportional hazards models were used to determine the effect of HOMA-IR on the risk of incident IS, myocardial infarction (MI), vascular death, and combined outcomes (IS, MI, and vascular death).
RESULTS: The mean (SD) HOMA-IR was 2.3 (2.1), and Q4 was at least 2.8. During mean follow-up of 8.5 years, vascular events occurred in 180 participants; 46 had fatal or nonfatal IS, 45 had fatal or nonfatal MI, and 121 died of vascular causes. The HOMA-IR Q4 vs less than Q4 significantly predicted the risk of IS only (adjusted hazard ratio, 2.83; 95% confidence interval, 1.34-5.99) but not other vascular events. This effect was independent of sex, race/ethnicity, traditional vascular risk factors, and metabolic syndrome and its components.
CONCLUSIONS: Insulin resistance estimated using the HOMA is a marker of increased risk of incident stroke in nondiabetic individuals. These findings emphasize the need to better characterize individuals at increased risk for IS and the potential role of primary preventive therapies targeted at IR.
Authors:
Tatjana Rundek; Hannah Gardener; Qiang Xu; Ronald B Goldberg; Clinton B Wright; Bernadette Boden-Albala; Norbelina Disla; Myunghee C Paik; Mitchell S V Elkind; Ralph L Sacco
Related Documents :
17027336 - Metabolic disturbances in chronic heart failure: a case for the "macho" approach with t...
16197926 - Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and n...
19476476 - Pioglitazone decreases postprandial accumulation of remnant lipoproteins in insulin-res...
18309686 - Differences in insulin sensitivity and secretory capacity based on ogtt in subjects wit...
7192386 - Tubular extrusion of d-glucose in the isolated rabbit kidney perfused in vitro.
402276 - Insulin disappearance rate in pregnant and non-pregnant women, and in non-pregnant wome...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Archives of neurology     Volume:  67     ISSN:  1538-3687     ISO Abbreviation:  Arch. Neurol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-12     Completed Date:  2010-10-29     Revised Date:  2010-12-03    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1195-200     Citation Subset:  AIM; IM    
Affiliation:
Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. trundek@med.miami.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Cohort Studies
Community Health Planning
Enzyme-Linked Immunosorbent Assay / methods
Female
Humans
Insulin / blood
Insulin Resistance*
Male
Middle Aged
Myocardial Infarction / blood,  epidemiology
New York City / epidemiology,  ethnology
Retrospective Studies
Risk Factors
Stroke / blood,  epidemiology*
Vascular Diseases / blood,  epidemiology
Grant Support
ID/Acronym/Agency:
2 M01 RR00645/RR/NCRR NIH HHS; K23 NS42912/NS/NINDS NIH HHS; R37 NS029993-17S1/NS/NINDS NIH HHS; R37 NS029993-19/NS/NINDS NIH HHS; R37/R01 29993//PHS HHS
Chemical
Reg. No./Substance:
11061-68-0/Insulin
Comments/Corrections
Comment In:
Arch Neurol. 2010 Oct;67(10):1177-8   [PMID:  20937943 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple ...
Next Document:  Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis ...